<DOC>
	<DOCNO>NCT00196326</DOCNO>
	<brief_summary>This open-label , single treatment study . All subject receive one year oral contraceptive therapy DR-1011 . Study participant receive physical gynecological exam , include Pap smear . During study , participant require complete diary .</brief_summary>
	<brief_title>Open-label Study Evaluate Efficacy Safety Extended-cycle , Low Dose Combination Oral Contraceptive</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Premenopausal Not pregnant breastfeed Sexually active risk pregnancy Any contraindication use oral contraceptive Pregnancy within last 3 month Smoking &gt; 10 cigarette per day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>pregnancy prevention</keyword>
	<keyword>oral contraceptive</keyword>
</DOC>